Brief: Longeveron Publishes Peer Reviewed Study Of Phase 1 Trial Results Of Lomecel-B For Alzheimer's
31/03/2022 13:46
March 31 (Reuters) - Longeveron Inc LGVN.O :
* LONGEVERON PUBLISHES PEER REVIEWED STUDY OF PHASE 1 TRIAL
RESULTS OF LOMECEL-B FOR ALZHEIMER’S DISEASE IN ALZHEIMER’S &
DEMENTIA®: THE JOURNAL OF THE ALZHEIMER’S ASSOCIATION
Source text for Eikon: ID:nGNX9D2XKB
Further company coverage: LGVN.O
((Reuters.Briefs@thomsonreuters.com;))